Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0027121 (myositis)
 4,538 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Pathological examinations of 28 wild-caught Mastomys natalensis from Sierra Leone, 14 of which were positive for Lassa virus by tissue culture, are reported. The high frequency of neoplastic and degenerative diseases observed among older animals in closed colonies of M. natalensis were not observed in the wild animals studied. This is probably a reflection of the age distribution of the study population, since the life expectancy of wild Mastomys is less than a year. Inflammatory lesions were nonetheless identified, some of which were similar to those described in laboratory colonies. Frequent lesions were myocarditis (54%), myositis (32%), interstitial pneumonitis (50%), intercapillary glomerulosclerosis (36%), and acute nephrosis (14%). Follicular and nodular lymphoid hyperplasia were evident in the spleen (74%) and Peyer's patches (64%). Lymphoid cell accumulations were prominent in the salivary glands (36%), periportal hepatic region (25%), lungs (32%), perivascular regions (36%), and kidney (21%). Cytomegalic inclusion body sialoadenitis was common (25%). Coccidiosis was evident in the intestinal tract (25%), kidney (25%), and muscle (21%). One neoplasm, a parahepatic haemangioma, was observed histologically.Mean body weights and lengths for virus-positive animals (33 g and 9.2 cm) and virus-negative animals (54 g and 12.2 cm) showed that virus-positive animals were smaller in weight and shorter in length. Since the age of the animals could not be determined, these differences remain unexplained.In comparison with virus-negative animals, virus-positive Mastomys had higher frequencies of splenic follicular hyperplasia (82% against 50%), myocarditis (79% against 29%), perivascular lymphoid cell accumulation (57% against 7%), myositis (50% against 14%), and cytomegalic inclusion body sialoadenitis (36% against 14%). The frequency of lymphoid hyperplasia of Peyer's patches was high in both groups of animals (71% and 57%).The presence of Lassa virus, small size, myocarditis, and lymphoid perivasculitis appeared to be interrelated, but larger and better controlled studies are required to elucidate the relationship.
 ...
PMID:Lassa virus infection in Mastomys natalensis in Sierra Leone. Gross and microscopic findings in infected and uninfected animals. 108 21

Hyperlipidemia is common in patients with glomerular proteinuria. It may contribute to atherosclerotic complications and accelerate glomerular damage. Early trials of the fibric acid derivative clofibrate led to a myositis syndrome causing many nephrologists to abandon attempts at treatment of nephrotic hyperlipidemia. Recent trials with lipid-lowering medications have been successful without major side effects. The bile acid sequestrants colestipol and cholestyramine bind bile acids in the gut and deplete the hepatic cholesterol pool, thus inducing LDL hepatocyte receptors. Recent studies showed a reduction of total cholesterol of 8-20% and LDL cholesterol of 19-31% without significant changes in HDL cholesterol. Probucol has reduced total cholesterol 23-30% and LDL cholesterol 23-25% in nephrotic patients. Although HDL cholesterol was reduced, the LDL/HDL ratio remains favorably changed. The fibric acid derivative gemfibrozil inhibits adipose lipolysis and enhances lipoprotein lipase activity thus decreasing LDL synthesis and increasing its removal. It caused a large decrease in triglycerides with a 13-15% decrease in total and LDL cholesterol in a recent trial. HDL cholesterol increased 18%. The HMG-CoA reductase inhibitors inhibit the rate-limiting step in cholesterol biosynthesis hence inducing an increase in LDL receptors on hepatocytes. Trials have shown decreases of 18-36% in total cholesterol and 18-47% in LDL cholesterol, while HDL cholesterol was either increased or unchanged. The use of lipid-lowering agents of several classes has been effective in ameliorating the progression of glomerular damage in a number of different models of glomerulosclerosis. Nevertheless, so far in humans lipid lowering drugs have not been established to have an effect on either the degree of proteinuria or the progression of glomerulosclerosis.
 ...
PMID:Lipid-lowering agents in proteinuric diseases. 225 70